When do HIV-infected women disclose their HIV status to their male partner and why? A study in a PMTCT programme, Abidjan.
BACKGROUND: In Africa, women tested for HIV during antenatal care are counselled to share with their partner their HIV test result and to encourage partners to undertake HIV testing. We investigate, among women tested for HIV within a prevention of mother-to-child transmission of HIV (PMTCT) program...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2007-12-01
|
| Series: | PLoS Medicine |
| Online Access: | http://europepmc.org/articles/PMC2100145?pdf=render |
| _version_ | 1819265997954088960 |
|---|---|
| author | Hermann Brou Gérard Djohan Renaud Becquet Gérard Allou Didier K Ekouevi Ida Viho Valériane Leroy Annabel Desgrées-du-Loû ANRS 1201/1202/1253 Ditrame Plus Study Group |
| author_facet | Hermann Brou Gérard Djohan Renaud Becquet Gérard Allou Didier K Ekouevi Ida Viho Valériane Leroy Annabel Desgrées-du-Loû ANRS 1201/1202/1253 Ditrame Plus Study Group |
| author_sort | Hermann Brou |
| collection | DOAJ |
| description | BACKGROUND: In Africa, women tested for HIV during antenatal care are counselled to share with their partner their HIV test result and to encourage partners to undertake HIV testing. We investigate, among women tested for HIV within a prevention of mother-to-child transmission of HIV (PMTCT) programme, the key moments for disclosure of their own HIV status to their partner and the impact on partner HIV testing. METHODS AND FINDINGS: Within the Ditrame Plus PMTCT project in Abidjan, 546 HIV-positive and 393 HIV-negative women were tested during pregnancy and followed-up for two years after delivery. Circumstances, frequency, and determinants of disclosure to the male partner were estimated according to HIV status. The determinants of partner HIV testing were identified according to women's HIV status. During the two-year follow-up, disclosure to the partner was reported by 96.7% of the HIV-negative women, compared to 46.2% of HIV-positive women (chi(2) = 265.2, degrees of freedom [df] = 1, p < 0.001). Among HIV-infected women, privileged circumstances for disclosure were just before delivery, during early weaning (at 4 mo to prevent HIV postnatal transmission), or upon resumption of sexual activity. Formula feeding by HIV-infected women increased the probability of disclosure (adjusted odds ratio 1.54, 95% confidence interval 1.04-2.27, Wald test = 4.649, df = 1, p = 0.031), whereas household factors such as having a co-spouse or living with family reduced the probability of disclosure. The proportion of male partners tested for HIV was 23.1% among HIV-positive women and 14.8% among HIV-negative women (chi(2) = 10.04, df = 1, p = 0.002). Partners of HIV-positive women who were informed of their wife's HIV status were more likely to undertake HIV testing than those not informed (37.7% versus 10.5%, chi(2) = 56.36, df = 1, p < 0.001). CONCLUSIONS: In PMTCT programmes, specific psychosocial counselling and support should be provided to women during the key moments of disclosure of HIV status to their partners (end of pregnancy, weaning, and resumption of sexual activity). This support could contribute to improving women's adherence to the advice given to prevent postnatal and sexual HIV transmission. |
| first_indexed | 2024-12-23T20:54:16Z |
| format | Article |
| id | doaj.art-c132ddca285549ffa0565da247b58185 |
| institution | Directory Open Access Journal |
| issn | 1549-1277 1549-1676 |
| language | English |
| last_indexed | 2024-12-23T20:54:16Z |
| publishDate | 2007-12-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS Medicine |
| spelling | doaj.art-c132ddca285549ffa0565da247b581852022-12-21T17:31:35ZengPublic Library of Science (PLoS)PLoS Medicine1549-12771549-16762007-12-01412e34210.1371/journal.pmed.0040342When do HIV-infected women disclose their HIV status to their male partner and why? A study in a PMTCT programme, Abidjan.Hermann BrouGérard DjohanRenaud BecquetGérard AllouDidier K EkoueviIda VihoValériane LeroyAnnabel Desgrées-du-LoûANRS 1201/1202/1253 Ditrame Plus Study GroupBACKGROUND: In Africa, women tested for HIV during antenatal care are counselled to share with their partner their HIV test result and to encourage partners to undertake HIV testing. We investigate, among women tested for HIV within a prevention of mother-to-child transmission of HIV (PMTCT) programme, the key moments for disclosure of their own HIV status to their partner and the impact on partner HIV testing. METHODS AND FINDINGS: Within the Ditrame Plus PMTCT project in Abidjan, 546 HIV-positive and 393 HIV-negative women were tested during pregnancy and followed-up for two years after delivery. Circumstances, frequency, and determinants of disclosure to the male partner were estimated according to HIV status. The determinants of partner HIV testing were identified according to women's HIV status. During the two-year follow-up, disclosure to the partner was reported by 96.7% of the HIV-negative women, compared to 46.2% of HIV-positive women (chi(2) = 265.2, degrees of freedom [df] = 1, p < 0.001). Among HIV-infected women, privileged circumstances for disclosure were just before delivery, during early weaning (at 4 mo to prevent HIV postnatal transmission), or upon resumption of sexual activity. Formula feeding by HIV-infected women increased the probability of disclosure (adjusted odds ratio 1.54, 95% confidence interval 1.04-2.27, Wald test = 4.649, df = 1, p = 0.031), whereas household factors such as having a co-spouse or living with family reduced the probability of disclosure. The proportion of male partners tested for HIV was 23.1% among HIV-positive women and 14.8% among HIV-negative women (chi(2) = 10.04, df = 1, p = 0.002). Partners of HIV-positive women who were informed of their wife's HIV status were more likely to undertake HIV testing than those not informed (37.7% versus 10.5%, chi(2) = 56.36, df = 1, p < 0.001). CONCLUSIONS: In PMTCT programmes, specific psychosocial counselling and support should be provided to women during the key moments of disclosure of HIV status to their partners (end of pregnancy, weaning, and resumption of sexual activity). This support could contribute to improving women's adherence to the advice given to prevent postnatal and sexual HIV transmission.http://europepmc.org/articles/PMC2100145?pdf=render |
| spellingShingle | Hermann Brou Gérard Djohan Renaud Becquet Gérard Allou Didier K Ekouevi Ida Viho Valériane Leroy Annabel Desgrées-du-Loû ANRS 1201/1202/1253 Ditrame Plus Study Group When do HIV-infected women disclose their HIV status to their male partner and why? A study in a PMTCT programme, Abidjan. PLoS Medicine |
| title | When do HIV-infected women disclose their HIV status to their male partner and why? A study in a PMTCT programme, Abidjan. |
| title_full | When do HIV-infected women disclose their HIV status to their male partner and why? A study in a PMTCT programme, Abidjan. |
| title_fullStr | When do HIV-infected women disclose their HIV status to their male partner and why? A study in a PMTCT programme, Abidjan. |
| title_full_unstemmed | When do HIV-infected women disclose their HIV status to their male partner and why? A study in a PMTCT programme, Abidjan. |
| title_short | When do HIV-infected women disclose their HIV status to their male partner and why? A study in a PMTCT programme, Abidjan. |
| title_sort | when do hiv infected women disclose their hiv status to their male partner and why a study in a pmtct programme abidjan |
| url | http://europepmc.org/articles/PMC2100145?pdf=render |
| work_keys_str_mv | AT hermannbrou whendohivinfectedwomendisclosetheirhivstatustotheirmalepartnerandwhyastudyinapmtctprogrammeabidjan AT gerarddjohan whendohivinfectedwomendisclosetheirhivstatustotheirmalepartnerandwhyastudyinapmtctprogrammeabidjan AT renaudbecquet whendohivinfectedwomendisclosetheirhivstatustotheirmalepartnerandwhyastudyinapmtctprogrammeabidjan AT gerardallou whendohivinfectedwomendisclosetheirhivstatustotheirmalepartnerandwhyastudyinapmtctprogrammeabidjan AT didierkekouevi whendohivinfectedwomendisclosetheirhivstatustotheirmalepartnerandwhyastudyinapmtctprogrammeabidjan AT idaviho whendohivinfectedwomendisclosetheirhivstatustotheirmalepartnerandwhyastudyinapmtctprogrammeabidjan AT valerianeleroy whendohivinfectedwomendisclosetheirhivstatustotheirmalepartnerandwhyastudyinapmtctprogrammeabidjan AT annabeldesgreesdulou whendohivinfectedwomendisclosetheirhivstatustotheirmalepartnerandwhyastudyinapmtctprogrammeabidjan AT anrs120112021253ditrameplusstudygroup whendohivinfectedwomendisclosetheirhivstatustotheirmalepartnerandwhyastudyinapmtctprogrammeabidjan |